Levosimendan Alpha-Medical

Medicinal product

(Invented) name

Levosimendan Alpha-Medical

Active substance (s)

Levosimendanas

Strength

2,5 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01CX08, Levosimendan

Marketing authorisation holder

UAB Rx pharma, Lietuva

Date of authorisation

2026-01-09

Date of renewal

Documents

3111_Levosimendan Alpha-Medical_PZ_2026-01-09.docx

3111_Levosimendan Alpha-Medical_PL_2026-01-09.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml koncentrato yra:	1 ml
Levosimendanas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119770	105876	1105876	flakonas	5 ml N1	ASPĮ	Receptinis	LT/L/26/3111/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-01-09	Registruotas